While no obvious differences were found in phosphorylation of ERK and JNK (p-ERK and p-JNK), phosphorylated p38 was significantly activated (p-p38) after treatment with 20 μM of α-mangostin in cervical cancer cells (Figure 3A–3C). Here, MAPK8 is linked to cervical carcinoma.